Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085580 (
essential hypertension
)
14,686
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
At present great attention is paid to Ca2+ metabolic derangement in the pathogenesis of cardiovascular alterations. Some researchers interpret this derangement as change in the ratio of parathyroid secretory activity and thyroid C-cell activity. For this purpose the blood levels of
parathormone
and calcitonin were investigated by radioimmunoassay with simultaneous recording of lower limb hemodynamic indices in 136 patients with diabetes mellitus. Change of elasticity of major vessels, a decrease in the reserve blood flow, marked to a greater extent in patients over 40 and combined with
essential hypertension
, were observed. An increase in the blood levels of
parathormone
and calcitonin was also observed. Direct correlation was established in both age groups between the levels of
parathormone
and calcitonin and hemodynamic indices.
...
PMID:[Secretion of calcium-regulating hormones in diabetes mellitus]. 202 61
A total of 25 patients with
essential hypertension
received a hyponatrium, hypocaloric antisclerotic diet providing 800 mg Ca and 1100 mg P/day, during 18-20 days. As a result of the dietotherapy, Ca concentration in the patients' blood serum rose from 9.9 +/- 0.2 to 10.4 +/- 0.1 mg/100 ml (p = 0.02), total cholesterol level was lowered from 6.58 +/- 0.43 to 5.42 +/- 0.3 mmol/l (p less than 0.05), Na+ and K+ distribution between the blood plasma and red blood cells was improved, and the arterial blood pressure was normalized in all the patients investigated. It dropped from 162 +/- 3.8/102 +/- 1.8 mm Hg before the treatment to 129 +/- 2.1/83.4 +/- 2.2 mm Hg after the treatment. Additional intake of 850 mg Ca/day, as CaCO3, decreased
parathormone
level in the blood serum from 0.40 +/- 0.03 to 0.23 ng/ml (p less than 0.01), intensified the hypolipidemic effect of the ration, and did not influence the degree of arterial blood pressure reduction under the action of this ration. Optimization of Ca consumption plays an important role in the combined dietotherapy of
essential hypertension
.
...
PMID:[The effect of dietotherapy and supplementary calcium intake on phosphorus-calcium homeostasis in hypertensive patients]. 237 97
A total of 132 patients with stage I, II,
essential hypertension
were examined. Indices for central hemodynamics were determined as were the levels of
parathormone
, calcitonin, and ionized calcium. Radon baths in eukinetic and hypokinetic types of circulation caused a significant reduction in mean hemodynamic pressure and resulted in improvement of patency of arterioles. In so far as hyperkinetic type of hemodynamics is concerned, there was a significant reduction in cardiac index and an increase in specific peripheral resistance. The level of ionized calcium got increased in all the patients, the same being true of the levels of
parathormone
and calcitonin in cases of eukinetic and hyperkinetic types of circulation.
...
PMID:[The effect of radon baths at the Khmel'nik health resort on the central hemodynamic indices and calcium-regulating hormones in patients with essential hypertension]. 863 Aug 22
A high prevalence of hypercalciuria has been reported in patients with
essential hypertension
. Nevertheless, the clinical and therapeutic implications of this finding have scarcely been studied. This study was designed to determine the prevalence of hypercalciuria in an unselected population with
essential hypertension
and to analyze the relationship between the urinary calcium and the clinical and therapeutic status of these patients. This article presents a prospective study of 112 patients with
essential hypertension
and 49 healthy normotensive control subjects. Urinary excretion rates of calcium, sodium, chloride, potassium, urinary calcium/creatinine index, the fractional excretion of sodium, potassium and uric acid, the creatinine clearance and serum values of creatinine, urea, uric acid, electrolytes, total proteins,
parathormone
(intact molecule), plasma renin activity, aldosterone, glucose, and insulin (fasting and after an oral glucose load) were performed in every patient and control subject. Untreated hypertensive patients had a higher prevalence of hypercalciuria (35% had a urinary calcium/creatinine ratio > 0.20 versus 20% of treated hypertensives and 2% of control subjects; P < 0.001). Patients on thiazide or beta-blocker monotherapy had lower urinary excretion rates of calcium and urate than patients on calcium-antagonist monotherapy or untreated patients. Urinary calcium, sodium, and urate correlated positively both in treated and untreated
essential hypertension
patients. Patients with the higher urinary calcium levels also had higher excretion rates of sodium and urate, higher creatinine clearance rates, and lower serum creatinine and serum uric acid levels. It was concluded that hypercalciuria is a frequent finding of untreated
essential hypertension
. The association of high urinary calcium levels with high urinary urate excretion rates in the same patient may predispose to development of lithiasis in patients with
essential hypertension
. Antihypertensive drugs have a variable effect on calciuria-uricosuria, which may constitute an additional criterion in the selection and individualization of therapy. Thiazides and beta-blockers can decrease calciuria and uricosuria and, therefore, the lithogenic risk in these patients.
...
PMID:Urinary calcium excretion in treated and untreated essential hypertension. 882 22
We evaluated the effect of oral calcium supplementation on blood pressure, calcium metabolism, and insulin resistance in
essential hypertension
. After receiving a standard diet with 500 mg of calcium per day during a 4-week period, 20 nondiabetic, essential hypertensive patients were randomized in a double-blind fashion to receive oral calcium supplementation (1500 mg of calcium per day) or placebo for 8 weeks. At the end of the 4-week period of low-calcium diet and after the 8-week period of intervention, we measured blood pressure (by both office and 24-hour ambulatory blood pressure monitoring), calcium-regulating hormones [urinary hydroxyproline and serum osteocalcin,
parathormone
, and 1,25(OH)2-vitamin D3], intraplatelet free calcium concentration, fasting plasma glucose and insulin levels, and the insulin-sensitivity index (euglycemic-hyperinsulinemic clamp). Compared with patients maintained at low calcium intake, essential hypertensive patients under oral calcium supplementation significantly reduced serum osteocalcin (from 22.2 +/- 1.9 to 17.9 +/- 2.0 micrograms/L; P = .0015),
parathormone
(from 4.20 +/- 0.38 to 3.30 +/- 0.36 pmol/L; P = .0003), and 1,25(OH)2-vitamin D3 (from 98.0 +/- 11.0 to 61.6 +/- 5.7 pmol/L; P = .0062). Likewise, we found a significant reduction in intraplatelet free calcium concentration (from 35.9 +/- 1.2 to 26.5 +/- 0.8 nmol/L; P = .0005) and fasting plasma insulin levels (from 71.8 +/- 5.9 to 64.6 +/- 6.2 pmol/L; P = .05) and a significant increase in the insulin-sensitivity index (from 2.89 +/- 0.77 to 4.00 +/- 0.95 mg.kg-1.min-1; P = .0007). None of these parameters were significantly modified in patients maintained at low calcium intake. Office and 24-hour mean values of systolic and diastolic blood pressure did not change after 8 weeks of oral calcium supplementation or placebo.
...
PMID:Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. 903 55
The regulation of blood pressure is complex with several organs being involved. Intracellular calcium plays a crucial role in the regulation of cardiovascular functions: An increased influx of calcium into the vascular smooth muscle cells leads to an augmental muscular tone and therefore to an increased vascular resistance and rise in blood pressure.
Parathormone
plays a permissive role since it regulates the calcium-influx into the cells and thus increases the vasoconstrictive effect. There is a positive correlation between
parathormone
and blood pressure, present in primary as well as secondary hyperparathyroidism. Moreover, patients with
essential hypertension
have high
parathormone
levels already before hypertension is diagnosed. A calcium-rich diet (> 1000 mg calcium daily) slightly decreases blood pressure. This positive effect is due to
parathormone
suppression with a subsequently decreased calcium content in the vascular smooth muscle cells. A calcium-rich diet inhibits lipogenesis in the fat tissue; thus additionally improving the cardiovascular risk profile.
...
PMID:[Calcium and blood pressure]. 1768 82
Multiple factors underlie susceptibility to
essential hypertension
, including a significant genetic and ethnic component, and environmental effects. Blood pressure response of hypertensive individuals to salt is heterogeneous, but salt sensitivity appears more prevalent in people of indigenous African origin. The underlying genetics of salt-sensitive hypertension, however, are poorly understood. In this study, computational methods including text- and data-mining have been used to select and prioritize candidate aetiological genes for salt-sensitive hypertension. Additionally, we have compared allele frequencies and copy number variation for single nucleotide polymorphisms in candidate genes between indigenous Southern African and Caucasian populations, with the aim of identifying candidate genes with significant variability between the population groups: identifying genetic variability between population groups can exploit ethnic differences in disease prevalence to aid with prioritisation of good candidate genes. Our top-ranking candidate genes include
parathyroid hormone precursor
(
PTH
) and type-1 angiotensin II receptor (AGTR1). We propose that the candidate genes identified in this study warrant further investigation as potential aetiological genes for salt-sensitive hypertension.
...
PMID:Computational analysis of candidate disease genes and variants for salt-sensitive hypertension in indigenous Southern Africans. 2088